LUDWIG INSTITUTE FOR CANCER RESEARCH

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07K PEPTIDES 13532
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 129132
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 7790
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 6043
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 54152
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 3762
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 3788
 
  
 
C07D HETEROCYCLIC COMPOUNDS 9153
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 887
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 5133

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0145,391 TRUNCATED VARIANT OF THE MAMMALIAN TARGET FOR RAPAMYCIN (mTOR) PROTEINFeb 02, 17May 25, 17[C12Q, C12P, C12N, G01N, C07K]
2017/0008,976 ANTI-METALLOPROTEASE ANTIBODY FOR DIAGNOSIS AND TREATMENT OF CANCERSFeb 04, 15Jan 12, 17[G01N, C07K]
2016/0376,364 METHOD OF TREATING CANCERNov 28, 14Dec 29, 16[A61K, C12N, C07K]
2016/0272,976 PRODUCTS AND METHODS FOR TREATMENT OF FAMILIAL AMYOTROPHIC LATERAL SCLEROSISAug 26, 14Sep 22, 16[A61K, C12N]
2013/0289,253 REVERSIBLE PROTEIN MULTIMERS, METHODS FOR THEIR PRODUCTION AND USESep 30, 11Oct 31, 13[C07K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9880171 iASPP phosphorylation and metastatic potentialMar 01, 13Jan 30, 18[A61K, G01N, G06F, C07K]
9700532 iNKT cell modulators and methods of using the sameMay 12, 16Jul 11, 17[A61J, A61K, C07C, C07K]
9562102 Specific binding proteins and uses thereofDec 11, 12Feb 07, 17[A61K, C12N, C07K]
9534258 Devices and methods for prognosis prediction for melanoma cancerAug 29, 14Jan 03, 17[C07H, C12Q, C12P]
9518112 TGF-β1 specific antibodies and methods and uses thereofMar 06, 13Dec 13, 16[A61K, G01N, C07K]
9487579 Methods and compositions for modulation of blood-neural barrierMay 20, 14Nov 08, 16[A61K, C07K]
9469678 NY-ESO-1 peptides which bind to class II molecules and uses thereofMar 01, 04Oct 18, 16[A61K, C07K]
9410139 induces T cell responses against tumoral antigensSep 12, 08Aug 09, 16[A61K, C12N]
9365496 iNKT cell modulators and methods of using the sameNov 30, 12Jun 14, 16[A61J, A61K, C07C]
9314515 Targeted treatment for patients with estrogen receptor negative and progesterone receptor negative breast cancersApr 22, 09Apr 19, 16[A61K, G01N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0237,432 METHODS FOR MODULATING EXPRESSION OF C9ORF72 ANTISENSE TRANSCRIPTAbandonedOct 14, 14Aug 18, 16[C12N]
9260524 Specific binding proteins and uses thereofWithdrawnDec 11, 12Feb 16, 16[A61K, C12N, C07K]
2016/0000,894 IN VIVO EFFICACY OF NY-ESO-1 PLUS ADJUVANTAbandonedApr 28, 15Jan 07, 16[A61K, G01N]
2014/0322,130 SPECIFIC BINDING PROTEINS AND USES THEREOFAbandonedMar 26, 14Oct 30, 14[A61K, C07K]
2014/0255,436 IMMUNOGENIC COMPOSITIONS USEFUL IN PROVOKING AN INTEGRATED RESPONSE TO TUMOR ANTIGENSAbandonedApr 07, 14Sep 11, 14[A61K]
2014/0120,099 TRUNCATED VARIANT OF THE MAMMALIAN TARGET FOR RAPAMYCIN (mTOR) PROTEINAbandonedSep 24, 13May 01, 14[C12Q, C12N]
2014/0050,780 LIPOSOMAL FORMULATION OF NONGLYCOSIDIC CERAMIDES AND USES THEREOFAbandonedDec 22, 11Feb 20, 14[A61K]
2013/0302,277 METHOD OF TREATMENTAbandonedJul 30, 13Nov 14, 13[A61K]
2013/0224,249 RECOMBINANT TRYPANOSOMA CRUZI CELLS USEFUL AS ANTI-CANCER IMMUNE AGENTSAbandonedSep 01, 11Aug 29, 13[A61K, C12N]
8519109 Tumour rejection antigensExpiredFeb 03, 09Aug 27, 13[C07H]
8470989 CTSP cancer-testis antigensExpiredMay 02, 12Jun 25, 13[C07H, C12N]
8420791 Expression of FoxP3 by cancer cellsExpiredNov 27, 07Apr 16, 13[C07H]
2013/0039,910 METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS AND PERICYTE COMPOSITIONAbandonedApr 13, 12Feb 14, 13[A61K, A61P]
2013/0029,358 IMMUNODOMINANT MHC DR52B RESTRICTED NY-ESO-1 EPITOPES, MHC CLASS II MONOMERS AND MULTIMERS, AND USES THEREOFAbandonedOct 01, 10Jan 31, 13[G01N, C07K]
8357373 Methods for stimulating an immune response using bacterial antigen delivery systemExpiredOct 03, 06Jan 22, 13[A61K, A01N]
8354243 Method for determining presence of cancer in a sample by assaying for expression of ECSA/DPPA-2 nucleotide sequencesExpiredOct 02, 07Jan 15, 13[G01N]
2013/0011,496 CANCER TESTIS ANTIGENS AS BIOMARKERS IN NON-SMALL CELL LUNG CANCERAbandonedNov 23, 10Jan 10, 13[A61K, C12Q, G01N, A61P, C40B]
2012/0328,660 IMMUNOGENIC COMPOSITIONS USEFUL IN PROVOKING AN INTEGRATED RESPONSE TO TUMOR ANTIGENSAbandonedMay 31, 12Dec 27, 12[A61K, A61P]
2012/0283,115 SEROMIC ANALYSIS OF OVARIAN CANCERAbandonedAug 30, 10Nov 08, 12[B82Y, G01N, C40B]
2012/0238,478 PROTEIN MARKERS FOR THE DIAGNOSIS AND PROGNOSIS OF OVARIAN AND BREAST CANCERAbandonedMay 04, 12Sep 20, 12[C40B, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.